TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling

被引:112
作者
Abrahamsen, H
Baillie, G
Ngai, J
Vang, T
Nika, K
Ruppelt, A
Mustelin, T
Zaccolo, M
Houslay, M
Taskén, K
机构
[1] Univ Oslo, Ctr Biotechnol, N-0317 Oslo, Norway
[2] Univ Oslo, Sch Pharm, N-0317 Oslo, Norway
[3] Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland
[4] Canc Res Ctr, Program Signal Transduct, Burnham Inst, La Jolla, CA 92037 USA
[5] Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA
[6] Venetian Inst Mol Med, Padua, Italy
[7] Dulbecco Telethon Inst, Padua, Italy
基金
英国医学研究理事会;
关键词
D O I
10.4049/jimmunol.173.8.4847
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ligation of the TCR along with the coreceptor CD28 is necessary to elicit T cell activation in vivo, whereas TCR triggering alone does not allow a full T cell response. Upon T cell activation of human peripheral blood T cells, we found that the majority of cAMP was generated in T cell lipid rafts followed by activation of protein kinase A. However, upon TCR and CD28 coligation, beta-arrestin in complex with cAMP-specific phosphodiesterase 4 (PDE4) was recruited to lipid rafts which down-regulated cAMP levels. Whereas inhibition of protein kinase A increased TCR-induced immune responses, inhibition of PDE4 blunted T cell cytokine production. Conversely, overexpression of either PDE4 or beta-arrestin augmented TCR/CD28-stimulated cytokine production. We show here for the first time that the T cell immune response is potentiated by TCR/CD28-mediated recruitment of PDE4 to lipid rafts, which counteracts the local, TCR-induced production of cAMP. The specific recruitment of PDE4 thus serves to abrogate the negative feedback by cAMP which is elicited in the absence of a coreceptor stimulus.
引用
收藏
页码:4847 / 4858
页数:12
相关论文
共 67 条
[1]   Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase a type I [J].
Aandahl, EM ;
Moretto, WJ ;
Haslett, PA ;
Vang, T ;
Bryn, T ;
Tasken, K ;
Nixon, DF .
JOURNAL OF IMMUNOLOGY, 2002, 169 (02) :802-808
[2]   Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients [J].
Aandahl, EM ;
Aukrust, P ;
Skålhegg, BS ;
Müller, F ;
Froland, SS ;
Hansson, V ;
Taskén, K .
FASEB JOURNAL, 1998, 12 (10) :855-862
[3]   Protein kinase A intersects Src signaling in membrane microdomains [J].
Abrahamsen, H ;
Vang, T ;
Taskén, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) :17170-17177
[4]   Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor [J].
Acuto, O ;
Mise-Omata, S ;
Mangino, G ;
Michel, F .
IMMUNOLOGICAL REVIEWS, 2003, 192 (01) :21-31
[5]   T cell anergy and costimulation [J].
Appleman, LJ ;
Boussiotis, VA .
IMMUNOLOGICAL REVIEWS, 2003, 192 (01) :161-180
[6]   Regulation of T-cell activation by phosphodiesterase 4B2 requires its dynamic redistribution during immunological synapse formation [J].
Arp, J ;
Kirchhof, MG ;
Baroja, ML ;
Nazarian, SH ;
Chau, TA ;
Strathdee, CA ;
Ball, EH ;
Madrenas, J .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (22) :8042-8057
[7]   RETRACTED: β-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates β-adrenoceptor switching from Gs to Gi (Retracted Article) [J].
Baillie, GS ;
Sood, A ;
McPhee, I ;
Gall, I ;
Perry, SJ ;
Lefkowitz, RJ ;
Houslay, MD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) :940-945
[8]  
BANIYASH M, 1988, J BIOL CHEM, V263, P18225
[9]   THE HUMAN P50(CSK) TYROSINE KINASE PHOSPHORYLATES P56(LCK) AT TYR-505 AND DOWN REGULATES ITS CATALYTIC ACTIVITY [J].
BERGMAN, M ;
MUSTELIN, T ;
OETKEN, C ;
PARTANEN, J ;
FLINT, NA ;
AMREIN, KE ;
AUTERO, M ;
BURN, P ;
ALITALO, K .
EMBO JOURNAL, 1992, 11 (08) :2919-2924
[10]  
Bolger GB, 1997, BIOCHEM J, V328, P539